Ocugen (OCGN) Enterprise Value Growth (3y) (2017 - 2025)
Ocugen (OCGN) Enterprise Value Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 33.71% |
| Jun 30, 2024 | 49.33% |
| Mar 31, 2024 | 19.08% |
| Dec 31, 2023 | -17.97% |
| Sep 30, 2023 | -40.93% |
| Jun 30, 2023 | -67.69% |
| Mar 31, 2023 | -188.56% |
| Dec 31, 2022 | -130.31% |
| Sep 30, 2022 | -87.96% |
| Jun 30, 2022 | -453.42% |
| Mar 31, 2022 | -649.10% |
| Dec 31, 2021 | -287.81% |
| Sep 30, 2021 | -256.29% |
| Jun 30, 2021 | -139.58% |
| Mar 31, 2021 | -47.52% |
| Dec 31, 2020 | -44.42% |
| Sep 30, 2020 | -14.83% |
| Jun 30, 2020 | 6.89% |
| Mar 31, 2020 | 49.21% |
| Dec 31, 2019 | 38.44% |